Search / Trial NCT06226948

Using the Visualization for Lifestyle Change in Patients at Risk of Cardiovascular Diseases

Launched by UNIVERSITY MARIBOR · Jan 17, 2024

Trial Information

Current as of December 30, 2024

Active, not recruiting

Keywords

ClinConnect Summary

The investigators reviewed the existing literature and found little research on the use of Continuous Glucose Monitoring (CGM) and visualization of SCORE2 prognostic model in healthy populations and how they can influence lifestyle change. The investigators will conduct a randomised control trial with 3 intervention groups and 1 control gropu. The investigators also found that primary care nurses are still using paper-based methods to calculate CVDs by using colour-coded charts. Therefore, the investigators will use the visual tool of the SCORE2 scale to identify possible increased particip...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • individuals ages more than 40 years
  • without serious disease progression
  • at least one risk factor for CVDs
  • Exclusion Criteria:
  • individuals younger than 40 years
  • with serious disease progression
  • without risk factor for CVDs

About University Maribor

University Maribor, a leading research institution in Slovenia, is dedicated to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its robust academic framework and state-of-the-art facilities to conduct high-quality research that addresses pressing medical challenges. By fostering partnerships with industry stakeholders and healthcare providers, University Maribor aims to translate scientific discoveries into practical therapies, ultimately enhancing patient outcomes and contributing to the global body of medical knowledge.

Locations

Maribor, , Slovenia

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0